Literature DB >> 17194633

Array-CGH analysis and clinical description of 2q37.3 de novo subtelomeric deletion.

Sofia Kitsiou-Tzeli1, Carolina Sismani, Marios Ioannides, Stavros Bashiardes, Andria Ketoni, Vassiliki Touliatou, Aggeliki Kolialexi, Ariadni Mavrou, Emanuel Kanavakis, Philippos C Patsalis.   

Abstract

We report on a 13-year-old girl with normal karyotype and a de novo cryptic terminal deletion of chromosome 2q, detected by subtelomeric FISH analysis. Further investigation with array-CGH analysis using the 1Mb resolution Spectral Chip 2600 (Spectral Genomics) confirmed the deletion and also showed a deletion of four additional clones. No other abnormalities were detected by array-CGH. FISH studies using 8 BAC-probes were performed for fine mapping of the deletion and confirmed the array results. FISH analysis showed that the deletion breakpoint lies between clones RP11-84G18 and RP11-83N2 (physical distance between clones 0.36Mb) and extends to the telomere. The size of the deletion was estimated to be about 6.4-6.7Mb. Clinical findings include: developmental delay, severe behavioural disturbances, growth-pubertal retardation, congenital conductive mild hearing loss, growth hormone deficiency, compensate hypothyroidism, dysmorphic facial features, excessive joint hypermobility, brachymetaphalangy, abnormal dermatoglyphics and a history of neonatal laryngomalacia, hypotonia and umbilical hernia. The phenotype of our patient is in keeping with those of the literature, with the exception of cardiovascular, urogenital, neurological anomalies and eczema, which were not observed. The report of the clinical and molecular presentation of similar cases will allow accurate phenotype-genotype correlation and proper genetic counseling of the family.

Entities:  

Mesh:

Year:  2006        PMID: 17194633     DOI: 10.1016/j.ejmg.2006.09.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

1.  Autistic and dysmorphic features associated with a submicroscopic 2q33.3-q34 interstitial deletion detected by array comparative genomic hybridization.

Authors:  Duane T Brandau; Molly Lund; Linda D Cooley; Warren G Sanger; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2008-02-15       Impact factor: 2.802

2.  Paracentric inversion of chromosome 2 associated with cryptic duplication of 2q14 and deletion of 2q37 in a patient with autism.

Authors:  Françoise Devillard; Vincent Guinchat; Daniel Moreno-De-Luca; Anne-Claude Tabet; Nicolas Gruchy; Pascale Guillem; Marie-Ange Nguyen Morel; Nathalie Leporrier; Marion Leboyer; Pierre-Simon Jouk; James Lespinasse; Catalina Betancur
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

3.  The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.

Authors:  Camille Leroy; Emilie Landais; Sylvain Briault; Albert David; Olivier Tassy; Nicolas Gruchy; Bruno Delobel; Marie-José Grégoire; Bruno Leheup; Laurence Taine; Didier Lacombe; Marie-Ange Delrue; Annick Toutain; Agathe Paubel; Francine Mugneret; Christel Thauvin-Robinet; Stéphanie Arpin; Cedric Le Caignec; Philippe Jonveaux; Mylène Beri; Nathalie Leporrier; Jacques Motte; Caroline Fiquet; Olivier Brichet; Monique Mozelle-Nivoix; Pascal Sabouraud; Nathalie Golovkine; Nathalie Bednarek; Dominique Gaillard; Martine Doco-Fenzy
Journal:  Eur J Hum Genet       Date:  2012-10-17       Impact factor: 4.246

4.  Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.

Authors:  Jennifer L Roberts; Karine Hovanes; Majed Dasouki; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2013-11-02       Impact factor: 3.688

5.  Testicular sex cord-stromal tumor in a boy with 2q37 deletion syndrome.

Authors:  Yasunari Sakai; Ryota Souzaki; Hidetaka Yamamoto; Yuki Matsushita; Hazumu Nagata; Yoshito Ishizaki; Hiroyuki Torisu; Yoshinao Oda; Tomoaki Taguchi; Chad A Shaw; Toshiro Hara
Journal:  BMC Med Genomics       Date:  2014-04-22       Impact factor: 3.063

6.  2q37 Deletion syndrome confirmed by high-resolution cytogenetic analysis.

Authors:  Eun-Kyung Cho; Jinsup Kim; Aram Yang; Sung Yoon Cho; Dong-Kyu Jin
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-06-28

7.  Severe growth hormone deficiency and pituitary malformation in a patient with chromosome 2p25 duplication and 2q37 deletion.

Authors:  Annalisa Vetro; Sara Pagani; Margherita Silengo; Mariasavina Severino; Elena Bozzola; Cristina Meazza; Orsetta Zuffardi; Mauro Bozzola
Journal:  Mol Cytogenet       Date:  2014-06-19       Impact factor: 2.009

8.  Brachydactyly mental retardation syndrome with growth hormone deficiency.

Authors:  Alireza Arefzadeh; Pooyan Khalighinejad; Bahar Ataeinia; Pegah Parvar
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.